Addario Lung Cancer Medical Institute

This study looked at 62 people with ALK-positive lung cancer whose tumors had stopped responding to newer targeted drugs. Instead of a tissue biopsy, researchers used a simple blood test (liquid biopsy) to find genetic changes that cause drug resistance. The goal was to better un…